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Background: Effects of palm olein (POL) on calcium and fat metabolic balance and gastrointestinal (GI) tolerance
have been clinically evaluated but its use in combination with palm kernel oil (PKO), and canola oil has not been
similarly assessed in infants.
Methods: Calcium and fat balance and GI tolerance were evaluated in 33 healthy term infants (age = 68-159d) in a
randomized, double-blinded, 14d crossover trial at a day care center in Salvador, Brazil; followed by a 4d hospital
ward metabolic balance study in 17 of the male subjects. The study compared two commercially available milk-based
powdered formulas in Brazil; one containing POL (44% of total fat), PKO (21.7%) and canola oil (18.5%) as predominant
fats (PALM), and the other containing none (NoPALM). Occasional human milk (HM) supplementation was allowed at
home.
Results: Formula and HM intakes, and growth were not different (p > 0.05). Calcium absorption (%) for infants fed
NoPALM (58.8 ± 16.7%; means ± SD) was higher (p = 0.023) than those fed PALM (42.1 ± 19.2%), but was not significant
(p = 0.104) when calcium intake was used as a covariate. Calcium intake was higher (p < 0.001) in NoPALM versus
PALM fed infants. However, calcium retention (%) was higher in infants fed NoPALM compared to PALM with (p = 0.024)
or without (p = 0.015) calcium intake as a covariate. Fat absorption (%) for NoPALM was greater than PALM fed infants
(NoPALM = 96.9 ± 1.2 > PALM= 95.1 ± 1.5; p = 0.020 in Study Period I). Mean rank stool consistency was softer in
infants fed NoPALM versus PALM (p < 0.001; metabolic period). Adverse events, spit-up/vomit, fussiness and gassiness
were not different (p > 0.05). Formula acceptability was high and comparable for both formula feedings, regardless of
HM supplementation.
Conclusions: Term infants fed PALM based formula (containing palm olein, palm kernel and canola oils) demonstrated
lower calcium retention and fat absorption, and less softer stool consistency versus infants fed NoPALM based formula.
Study suggested formula fat differences may affect GI function in infants.
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Palm olein (POL) is included in the fat blend of most infant
formulas globally to mimic the relative amount of palmitic
acid (PA) in human milk [1]. However, the positional
distribution of individual fatty acids on the triacylglycer-
ide molecules (which affects fat absorption) differs be-
tween vegetable oils and human milk (HM) fat [1-4].
Fatty acids on the sn2-position are absorbed as the soluble
2-monoacylglycerides, and fatty acids on the sn1- and sn3-
positions are absorbed as free fatty acids. In vegetable oils,
including those used in infant formulas, the long chain sat-
urated fatty acids are located primarily on the sn1- and
sn3-positions [5]. After digestion, the free PA and stearic
acid (SA) conjugate with calcium to form insoluble calcium
soaps [6] resulting in reduced fat and calcium absorption.
In human milk, PA and SA are found primarily on the
sn2-positions (or beta-positions) on triacylglycerides, and
are well absorbed after digestion as 2-monoacylglycerides.
Currently available clinical studies (all done in the US
and Europe) have demonstrated that fat and calcium are
significantly less well absorbed from infant formulas
containing POL as the predominant fat source (40 – 45%
of total fat) compared to similar formulas containing no
POL [7-12]. Some of these studies [8,9] also reported hard
stools in the infants fed the POL-based formulas due to
increase in stool calcium soap formation. Hard stools have
also been reported in breast-fed infants weaned to a POL-
based formula [13]. These studies evaluated POL in com-
bination with other fats such as soy, coconut, high oleic
safflower or sunflower oils, but not with PKO, palm oil, or
canola oil. Moreover, none of these studies [7-12] evalu-
ated powdered formulations which are the predominant
form of infant formulas used globally. It is well known that
GI responses in infants can sometimes differ between li-
quid and powdered formulas because of differences in in-
gredients and manufacturing process [14]. Furthermore,
none of the formulations assessed in these studies [7-12]
contained supplemental Docosahexaenoic acid (DHA)
and Arachidonic Acid (ARA). Most standard infant for-
mulas in the US and many countries currently have DHA
and ARA.
In view of the above, the goal of this crossover study
was to assess the comparative calcium and fat metabolic
balance and gastrointestinal (GI) tolerance (including
stool consistency) in healthy normal term infants fed
two commercially available milk-based powdered formu-
las in Brazil; one containing POL, PKO and canola oils
as the major fats versus the other formula, which con-
tains none. Both formulas contain DHA and ARA.
Methods
Study design, subjects and ethics
This was a controlled, randomized, two treatments, double-
blinded, crossover balance and tolerance study. The trialwas conducted in two study periods, periods I and II. Each
period had a 14 day tolerance phase and a 4 day metabolic
balance phase (Figure 1). The study was approved by the
Institutional Research Board at the Federal University of
Bahia, Salvador, Brazil and was conducted in accordance
with ethical principles that have their origin in the Declar-
ation of Helsinki. The study was also registered with the
clinicaltrial.gov (#NCT00941564).
Infant subjects were enrolled and randomized into the
study in a day care center in Salvador, Bahia, Brazil. Sub-
jects were full term, healthy male and female infants be-
tween 84 and 156 ± 3 days of age at enrollment. They
were enrolled into the tolerance phase of the study upon
written informed consent from their parents.Study feedings
The two study formulas evaluated in this study were com-
mercially available powdered milk-based infant formula in
Brazil. One formula contained palm olein (POL), palm
kernel (PKO) and canola oils as the predominant fats
(PALM; Nestle NAN PRO 1™). The other formula con-
tained no POL, PKO or canola, but had high oleic sun-
flower (HOS), coconut and soy oils as major fats
(NoPALM; Similac Advance™). The NoPALM formula
contained higher levels of calcium and phosphorus
(Table 1). The two study formulas contained DHA and
ARA and comparable levels of vitamin D; and met the
levels of nutrients recommended by the Brazil Ministry of
Health (ANVISA), Codex Alimentarius [15] and Life Sci-
ences Research Office Expert Panel [16]. Study investiga-
tors, subjects and their parents were blinded to the
identity of the study formulas. Dedicated study nutrition-
ists handled study formula preparations and coding. The
nutritionists were not involved with the care and feeding
of infants, data collection and data handling.Evaluation procedures
Infants were enrolled into the study and randomized
into one of two feeding groups. The subjects were fed
the assigned study formulas exclusively at the day care
center during the day on weekdays in the 14-day toler-
ance phases of periods I and II. However, parents were
responsible for feeding the study formulas at home dur-
ing weekday evenings and nights, and weekends and
public holidays. Pre-measured study formula powder
and clean potable water were provided to parents with
training and clear instructions on formula reconstitu-
tion, storage and feeding. Parents agreed to feed the
assigned study formula as the primary source of nutri-
tion. However, occasional HM supplementation at home
was allowed when parents agreed to weigh the baby
and record baby weights before and after breast milk
feedings. Parents undertaking the HM supplementation
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Figure 1 Study flow chart and study subjects’ disposition.
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them.
Daily records of formula intake (volume and frequency),
incidence of spit-up and vomiting associated with feed-
ings, occurrence of fussiness, occurrence of gas, and in-
fant’s stool characteristics (frequency, consistency and
color) were kept by study personnel at the day care center
and by parents at home. Weights of subjects were mea-
sured daily at the daycare center and at the hospital by
study staffs; however, length and head circumference (HC)
were only measured at enrollment/study day 1 and at
study day 14 using published standard methods [18,19].
Male subjects who completed the 14-day tolerance
phase went through the additional 4-day metabolic phase
assessment in both study periods. Female subjects did not
undergo the metabolic assessment so as to avoid contam-
ination of stools with urine samples during collection. Themale subjects were admitted into the Metabolic Ward at
the Fima Lifshitz Metabolic Unit, The Hospital Professor
Edgar Santos, Federal University of Bahia, Salvador, Bahia,
Brazil, for 4 days. They continued to feed the assigned
study formula exclusively throughout the metabolic as-
sessment phase. No breast milk supplementation was al-
lowed during the metabolic assessment. However, mothers
of subjects who elected HM supplementation during study
tolerance phase continued breast-milk pumping in order
to maintain HM stimulation needed to resume HM feed-
ing after study completion. Metabolic assessment was
conducted with a 72 hours metabolic sample collection
and brilliant blue marker technic using published methods
[12,20,21]. Infants were kept on metabolic beds for 3
nights and 4 days. The beds were specially designed to ac-
curately collect separate urine and stool samples through-
out the metabolic assessment [19]. Intake, stool and GI
Table 1 Approximate composition of study formula
products (per 100 g of powder)
Nutrient* PALM NoPALM Brazil human milk
Referencea
Energy, kcal 519 513
Protein, g 9.5 11
Carbohydrate, g 57.9 55
Fat, g 27.7 28
Palm olein oil (%) 44
High oleic sunflower oil (%) 41.4
Palm kernel oil (%) 21.7
Coconut oil (%) 29.6





Fatty acids (g/100 g Fat)d
16:0 21.95 7.37 17.3 ± 2.2
16:1n-7 0.21 0.09 1.99 ± 0.74
18:0 3.34 3.06 5.3 ± 1.26
18:1n9 40.22 43.22 25.0 ± 3.46
18:2n-6 16.41 19.0 20.3 ± 6.48
18:3n-3 2.02 1.57 1.43 ± 0.66
20:4n-6 0.23 0.42 0.53 ± 0.14
20:5n-3 0.05 0.00 Trace
22:6n-3 0.23 0.16 0.14 ± 0.05
Minerals
Calcium, mg 279e 424e
Phosphorus, mg 160 216
Magnesium, mg 36 31.0
Vitamins
D, μg 7.8 8.6
*Values are manufacturer’s label claims, except where stated.
aSiloa MHL et al. [17].
bDocosahexaenoic acid (DHA), Arachidonic acid (ARA) and soy lecithin.
cDHA, and ARA.
dAnalytical values for fatty acids.
eInvestigator’s analytical values for calcium.
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period. Collected stool and urine samples were stored at
−80°C in the laboratory until analyzed. Stool samples were
analyzed for fat using the Folch method [22], and study
formula samples were analyzed by the method of Bligh
and Dyer [23]. Stool and study formula samples were also
separately analyzed for calcium using Varian Model 55B
atomic absorption spectrophotometer (Varian Medical
Systems, Inc., Palo Alto, CA), after acid digestion. Urine
samples were analyzed directly using the atomic absorptionspectrophotometer without acid treatment. All analyses were
done in duplicate.
Data and statistical analyses
The primary study variable was calcium absorption calcu-
lated from calcium intake, and fecal and urinary calcium.
The secondary variables included calcium retention, fat
absorption, mean rank stool consistency (MRSC scored
as 5 = watery, 4 = loose/mushy, 3 = soft, 2 = formed, 1 =
hard), and average number of stools per day. The sup-
portive variables included daily study product intake
(average volume and average number of feedings), daily
human milk intake, percent of feedings with spit up/
vomit associated with (within one hour) feeding per day;
predominant stool consistency and color, percentages of
stool consistency and color, occurrence of fussiness, oc-
currence of gas, and weight, length and HC; parental re-
sponses to the formula satisfaction questionnaire; and
study drop-out rate. Safety data included adverse events
(AEs) and serious adverse events (SAEs).
Mixed models for carryover data were used to analyze
metabolic balance outcomes. Tests for carryover effects
were two-sided, 0.10 level tests while tests for feeding
and period effects were two-sided, 0.05 level tests. When
carryover effects were significant, only Period I data re-
sults are valid. During the tolerance phase of the trial,
continuous data were analyzed using analysis of variance
and categorical data were analyzed using chi-square or
Fisher’s exact test. The arcsine of the square root trans-
formation was used for variables expressed as a percent-
age. Statistical analysis was performed using the SAS®
software version 9.1.3 (SAS Institute, Cary, NC). A sam-
ple size of 12 subjects (6 per sequence A to B and B to
A) has 80% power to detect a difference of at least 15%
in calcium absorption, assuming a standard deviation of
7.9%. Approximately 8 subjects per sequence were en-
rolled to account for 25% attrition. In the tolerance
phase, a sample size of 20 subjects per group has 80%
power to detect a difference of at least 0.55 in mean rank
stool consistency.
Results
Disposition, demographic, baseline characteristics and
anthropometry of subjects
A total of 33 subjects were enrolled and randomized
(PALM = 16; NoPALM= 17) into the study and contrib-
uted to the tolerance phase data (Figure 1). One subject
on NoPALM feeding had a SAE hospitalization with
pneumonia and exited the study prematurely. Thirty two
subjects completed the tolerance phase with 23 subjects
(PALM = 11; NoPALM= 12) consuming the assigned
study formula as the predominant source of nutrition.
Of these 23 subjects, 17 male subjects fed assigned study
formulas exclusively (no HM feeding) at the Hospital
Table 2 Study entrance information for subjects*
Variables PALM NoPALM p-values
Gestational age (weeks) 39.8 ± 1.2 (16) 39.5 ± 1.1 (17) 0.481
Mode of birth, vaginal/cesarean, (n/%) 12/4 (75/25) 11/6 (65/35) 0.708
Birth weight (g) 3333 ± 490 (16) 3321 ± 330 (17) 0.932
Birth length (cm) 49.1 ± 3.7 (15) 49.1 ± 1.9 (17) 0.965
Birth head circumference (cm) 33.7 ± 1.8 (15) 34.2 ±1.3 (15) 0.425
Age at study entrance (days) 117 ± 26 (16) 108 + 27 (17) 0.346
*Values are means ± SD (n).
Table 3 Intake and absorption of calcium and fat*
Variables Metabolic crossover phase
PALM NoPALM
(n = 17) (n = 17)
CALCIUM
Calcium Intake, mg/kg/day 48.3 ± 8.9 72.7 ± 11.8a
Stool calcium, mg/kg/day 27.9 ±10.1 30.3 ± 14.7
Calcium absorbed, mg/kg/day 20.4 ± 9.6 42.4 ± 14.6b
Calcium absorption, % 42.1 ±19.2 58.8 ± 16.7c
Urinary calcium, mg/kg/day 1.69 ± 0.85 1.43 ± 0.77
Calcium retention, mg/kg/day 18.7 ± 9.4 41.0 ± 14.5a
FAT
Fat intake, g/kg/day 4.7 ± 0.9 4.5 ± 0.7
Stool fat, g/kg/day 0.22 ± 0.08 0.14 ± 0.06d
Fat absorbed, g/kg/day 4.52 ± 0.85 4.33 ± 0.73
Fat absorption, % 95.1 ± 1.5 96.9 ± 1.2e
*Values are means ± SD.
a = p <0.001; b = p = 0.009; c = p = 0.023, but using calcium intake as covariate
yielded p = 0.104; d = Significant carryover effect (p = 0.071), therefore, valid
period I significant difference (p = 0.027).
e = Significant carryover effect (p = 0.059), therefore, valid period I significant
difference (p = 0.020).
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metabolic data during the crossover metabolic phase of
the study (PALM =17; NoPALM= 17).
There were no significant differences (p > 0.05) between
the two feeding groups in study entry information, study
completion rate, adverse events (AEs & SAEs), and other
demographic data (Table 2). The age of study subjects
ranged from 68 to 159 days and was not significantly dif-
ferent (p > 0.05). Male subjects were 56.3% of the PALM
fed group compared with 58.8% of the NoPALM fed
group but gender was not different. Birth weight, length,
head circumference and gestational age were not different
between the two feeding groups (p > 0.05).
There were no differences (P >0.05) in weight, length
and HC and their interval gains between the two for-
mula feedings during the study. Weights for male sub-
jects in the PALM and NoPALM fed groups at study day
1 were 7008 ± 777 g (means ± SD) and 6934 ± 951 g; and
those for female subjects were 6791 ± 1480 g and 6550 ±
1623 g, respectively. The 14 day weight gains for Male
subjects in the PALM and NoPALM fed groups were
295 ± 33 g and 374 ± 51 g; and for female subjects were
203 ± 46 g and 282 ± 70 g, respectively.
Metabolic balance assessment
Calcium intake, absorption and retention
There were no significant carryover effects in the calcium
metabolic data (Table 3). The intake of calcium was signifi-
cantly greater with the NoPALM feeding compared to the
PALM feeding (p < 0.001); however, there were no differ-
ences in stool calcium and urinary calcium. The percent
calcium absorption, which was the primary study variable
was significantly higher in the NoPALM versus PALM
feeding group (p = 0.023), but the significance disappeared
(p = 0.104) when calcium intake was used as a covariate in
the analyses. However, percent calcium retention was
higher in the NoPALM versus PALM feeding groups (p =
0.015), and remained higher (p = 0.024) even when calcium
intake was used as a covariate in the analyses (Figure 2).
Fat intake and absorption
There were no significant differences in fat intake be-
tween the formula feeding groups (p > 0.05) (Tables 3).There was a significant carryover effect (p = 0.071) noted
in the stool fat content; consequently, only study period
I results were regarded as valid. At study period I, the
stool fat content was significantly lower with the NoPALM
feeding compared with the PALM feeding (p = 0.027).
Similarly, there was a significant carryover effect (p =
0.059) noted with the percent fat absorption; thus, the
results of the study period I were the only valid results.
The NoPALM feeding group had a statistically (p = 0.020)
higher % fat absorption (~97%) versus the PALM feeding
group (~95%).
Formula gastrointestinal tolerance and acceptability
There were no significant differences (p > 0.05) in study
formula intake or HM intake between the two feeding
groups (Table 4). There was no HM intake during the
study metabolic phase; whereas, the majority of subjects
had HM supplementations during the study metabolic
phase. The average numbers of feeding per day were
38.5 + 19 















Figure 2 Calcium retention (%). NoPALM feeding had a significantly higher calcium retention (% Means ± SD) versus PALM feeding with (p = 0.024;
n = 17) or without (p = 0.015) calcium intake as covariate.
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with the PALM feeding during the tolerance phase, but
were not different during the metabolic phase. The oc-
currences of spit-up/vomit, fussiness and gassiness were
not different between the two study formula feedings
throughout the study. MRSC, the major GI study vari-
able was softer with the NoPALM feeding compared
with the PALM feeding (p <0.001) during the metabolic




Average study formula intake, mL/kg/d 113 ± 20
Average human milk intake, g/kg/d 0 ± 0
Average numbers of feedings, #/d 6.3 ± 0.2
Spit-up/vomit, % of feedings 4.0 ± 4.8
Stool frequency, # stools/d 3.4 ± 0.7
Mean rank stool consistency score (MRSC)‡ 2.4 ± 0.3
Stool consistency, % of stools
Watery 0 ± 0
Loose/mushy 1.2 ± 3.5
Soft 39.7 ± 26.5
Formed 59.1 ± 25.7
Hard 0 ± 0
Total stool production, g/kg/day 5.2 ± 2.3
Stool moisture content, % 82.8 ± 2.6
*Values are means ± SD.
**Sample sizes (n) for each column are in parenthesis except where noted to be dif
‡MRSC score: 5 = watery, 4 = loose/mushy, 3 = soft, 2 = formed, 1 = hard (higher is so
a = p <0.036; b = p = 0.001; c = Significant carryover effect (p = 0.077) Period I only, PALMNoPALM feeding (p < 0.036). The percentage of loose/
mushy stools was significantly higher (p = 0.002) during
the tolerance phase and the percentage of formed stools
was significantly lower (p < 0.001) during the metabolic
phase with the NoPALM feeding compared with the
PALM feeding group, respectively. MRSC was positively
correlated with percent loose/mushy stools (r = 0.80; p <
0.001), percent watery stools (r = 0.39; p = 0.024) and
percent stool moisture content (r = 0.35; p = 0.043). Theolerance, and stool characteristics*
eriod Tolerance period
NoPALM PALM NoPALM
(n = 17) (n = 16) (n = 17)
114 ± 19 99 ± 31 103 ± 33
0 ± 0 94 ± 36 (n = 15) 81 ± 29 (n = 12)
6.2 ± 0.1 4.6 ± 0.6 5.4 ± 0.9d
3.5 ± 4.7 12.8 ± 25.5 13.9 ± 21.4
2.9 ± 0.9a 1.7 ± 0.6 1.9 ± 0.7
3.0 ± 0.5b 3.3 ± 0.5 3.5 ± 0.6
0.5 ± 2 27.5 ± 19 26.9 ± 19.9
19.2 ± 21.6c 19.1 ± 17.2 38.2 ± 14.2e
58.9 ± 30.8 43.7 ± 18.9 32.6 ± 23.8
21.4 ± 35.8a 21.6 ± 12.5 20.7 ± 16.3





= 0.9 ± 2.8 & NoPALM= 8.3 ± 11.7 (NS at p = 0.122); d = p = 0.005; e = p = 0.002.
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different between the two formula feedings. Formula sat-
isfaction questionnaire responses by parents of subjects
in the study revealed that both study formulas were
similarly well tolerated.
Discussion
The results of the current study successfully demon-
strated that calcium metabolic balance (absorption or re-
tention) was significantly higher with the NoPALM
formula feeding compared to the PALM formula feeding
(containing POL, PKO and canola oils). The results are
consistent with those obtained in previous studies [7,11]
comparing calcium absorption and/or retention from
POL predominant milk-based formulas versus non-POL
containing formulas. The POL formulas evaluated in
those previous studies contained other vegetables oils in-
stead of PKO or canola oils. Consequently, the effects of
POL predominant formulas on calcium absorption are
consistent, irrespective other combinations of oil with
POL. The calcium absorption value of 58.8% versus
42.1% for the NoPALM (non-POL) versus PALM (POL)
formula noted in the current study is consistent with the
values of 57.4% versus 37.5% for the non-POL versus
POL formula reported by Nelson et al. [7]. Similarly, the
relative calcium retention value of 56.8% versus 38.5%
for the NoPALM versus PALM formula shown in our
current study is directionally consistent with the value of
47.2% versus 32.5% for the non-POL versus POL for-
mula previously reported in subsequent study by Nelson
et al. [11]. The fat balance results are also comparable to
those reported in the previous studies [7,11]. Notwith-
standing the differences in fat blend compositions (with
or without PKO, canola, DHA and ARA oils) and for-
mula types (powder versus liquid) of the formulas evalu-
ated in our current study versus previous studies, the
findings regarding the impact of POL predominant for-
mulas on calcium and fat balance are similar.
Historically, the percent calcium bioavailability from
infant formulas was assumed to be about 38% versus
58% for human milk [24,25]. Consequently, higher levels
of calcium were added to infant formulas, especially soy-
based formulas and specialized formulas so as to com-
pensate for their lower calcium bioavailability. However,
not all infant formulas typically have a lower calcium
bioavailability. Standard milk-based formulas containing
no POL have been shown [7,11] to have a calcium bio-
availability that is closer to that for human milk (HM).
The calcium bioavailability from the PALM formula in
the current study is close to the average value of 58% re-
ported for HM [24]. Furthermore, the percent fat ab-
sorption noted in the present study was greater in the
NoPALM group compared to the PALM group. The per-
cent fat absorption (~95 – 97%) from both study formulagroups was good and comparable to that reported from
HM [26].
The relevance of the higher calcium balance noted
with the NoPALM versus PALM feeding in the current
study is not diminished by the observed impact of cal-
cium intake on the percent calcium absorption when
used as a covariate. First, calcium absorption has been
suggested to be enhanced at lower calcium concentra-
tion and reduced at higher concentration [27,28]. None-
theless, calcium absorption will also depend on many
other factors as well. It is well accepted that calcium ab-
sorption from HM is significantly higher than that from
many infant formulas despite the lower level of calcium in
HM and the consequential lower intake of calcium from
HM [24,25]. Obviously, the lower level of calcium in the
PALM in this study did not result in enhanced calcium
absorption as in HM. Secondly, the significantly lower
percent calcium retention noted with the PALM feeding
was maintained after adjusting for calcium intake as a co-
variate in the analyses of variance. This suggests that the
differences in the fat blends of the study formulas have
relevant impact on the calcium balance noted in the study.
Calcium retention and bone mineral content are better
markers or functional outcomes for the impact of dietary
calcium on calcium homeostasis compared to calcium ab-
sorption [29]. A recently published study [30] demon-
strated a significantly (p = 0.041) lower bone mineral
content at 3 months of age in term infants fed a POL con-
taining partially hydrolyzed whey protein-based formula
compared to a similar formula containing no POL. The
fat blends of formulas compared in that study were similar
to the PALM and NoPALM formulas assessed in our
current study except for the inclusion of PKO and canola
in the PALM formula of our current study.
There were notable differences in the GI tolerance of
the study formulas by the subjects in the current study.
MRSC was soft for the NoPALM feeding group, and
formed for the PALM feeding group (Table 4). The stool
consistency results in this study were similar to those
observed in studies assessing the GI tolerance to formu-
las containing POL and those without POL. Studies have
reported an increase in the formation of calcium soap-
containing hard/firm stools in infants fed formula with
POL as the predominant oil compared to infants fed ei-
ther similar formulas containing no POL or infants fed
HM [8,9,12,13].
The original intent of the current study was to allow
minimal HM supplementation when the infant subjects
were at home and not at the day care center or at the
Hospital Metabolic Ward during this study. This was to
accommodate nights, weekends and holidays. Despite
the provision of study formulas to parents for home
feeding, the feeding of human milk was substantial in
this study. However, the HM supplementation intake was
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(Table 4). Previous metabolic studies on POL predomin-
ant formulas (7–12) which were all done in the US or
Europe did not report extensive HM supplementation.
Nonetheless, it was interesting and reassuring that differ-
ences in clinical outcomes were reasonably obtained
from feeding different types of formulas, even when HM
supplementation was substantial. The results of the
current study suggested that infant formula fat blend dif-
ferences may affect calcium and fat balance and GI stool
tolerance in formula fed infants receiving HM supplemen-
tations. However, this study did not address the amount of
formula feeding or HM supplementation that might pos-
sibly eclipse the differences noted in the current study.
Conclusions
In this study, the NoPALM powdered formula, which
was free of POL or PKO or canola, demonstrated signifi-
cantly higher calcium retention, and a higher fat absorp-
tion in healthy term infants, compared to the PALM
powdered formula, which contained palm olein (POL)
palm kernel (PKO) and canola oils as the predominant
fat, regardless of HM supplementation. The NoPALM
fed infants also demonstrated a softer stool consistency
compared to PALM fed infants; however, both PALM
and NoPALM fed infants generally demonstrated com-
parable normal GI tolerance and acceptability despite
the HM supplementation. The results of this study in
Brazilian infants are consistent with the results of previ-
ous studies on POL predominant formula despite differ-
ences in other fats combined with POL, the type of
formula (powder versus liquid) and HM supplementa-
tion. In conclusion, results of this study suggest that dif-
ferences in fat blends used in infant formulas may affect
calcium and fat metabolic balance, and GI stool toler-
ance in term infants.
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